Abstract:
The labeling method for
177Lu-DTPA-BIS-BIOTIN was established, and the biodistribution of
177Lu-DTPA-BIS-BIOTIN in normal mice was carried out as well. Under the optimal experimental condition (DTPA-BIS-BIOTIN 25 μg,pH=4.5 reacting at 80℃ for 20 min), the labeling yield of
177Lu-DTPA-BIS-BIOTIN is more than 99.0%.
177Lu-DTPA-BIS-BIOTIN shows pretty good in vitro stability. The biodistribution of
177Lu-DTPA-BIS-BIOTIN in normal mice shows a rapid blood clearance. The uptake of
177Lu-DTPA-BIS-BIOTIN is mainly accumulated in liver, spleen and kidney.
177Lu-DTPA-BIS-BIOTIN is excreted by kidney. The results provide the basis for further study on
177Lu-DTPA-BIS-BIOTIN used in pretargeted radioimage and radiotherapy of cancer.